Yongsung Ko
Pohang University of Science and Technology
About the Lab
Professor Yongsung Ko's research lab focuses on host-pathogen interactions, particularly in infectious diseases and asthma immunopathology. The lab investigates the role of extracellular vesicles (EVs) derived from Gram-negative bacteria, such as *Klebsiella pneumoniae*, as potential vaccine candidates to induce innate immunity and protect against lethal infections. Additionally, the lab explores the immunological mechanisms underlying severe asthma phenotypes, especially non-eosinophilic and virus-associated asthma, with a focus on cytokines (e.g., IFN-γ, IL-4, IL-13), growth factors (e.g., FGF2), and nitric oxide synthases. The lab also develops novel peptide-based therapeutics targeting angiogenesis in cancer, particularly VEGF inhibitors with enhanced stability and efficacy.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
8The emergence of multidrug-resistant Klebsiella pneumoniae highlights the need to develop preventive measures to ameliorate Klebsiella infections. Bacteria-derived extracellular vesicles (EVs) are spherical nanometer-sized proteolipids enriched with outer membrane proteins. Gram-negative bacteria-derived EVs have gained interest for use as nonliving complex vaccines. In the present study, we evaluated whether K. pneumoniae-derived EVs confer protection against bacteria-induced lethality. K. pneu
All living cells release extracellular vesicles having pleiotropicfunctions in intercellular communication. Mammalian extracellularvesicles, also known as exosomes and microvesicles,are spherical bilayered proteolipids composed of variousbioactive molecules, including RNAs, DNAs, proteins, andlipids. Extracellular vesicles directly and indirectly control adiverse range of biological processes by transferring membraneproteins, signaling molecules, mRNAs, and miRNAs, andactivating receptors of rec
Recent clinical evidence indicates that the non-eosinophilic subtype of severe asthma is characterized by fixed airway obstruction, which may be related to emphysema. Transgenic studies have demonstrated that high levels of IFN-γ in the airways induce emphysema. Fibroblast growth factor 2 (FGF2), which is the downstream mediator of TGF-β, is important in wound healing. We investigated the role of FGF2 in IFN-γ-induced emphysema and the therapeutic effects of recombinant FGF2 in the prevention of
IL-4 and IL-13 are closely related cytokines that are produced by Th2 cells. However, IL-4 and IL-13 have different effects on the development of asthma phenotypes. Here, we evaluated downstream molecular mechanisms involved in the development of Th2 type asthma phenotypes. A murine model of Th2 asthma was used that involved intraperitoneal sensitization with an allergen (ovalbumin) plus alum and then challenge with ovalbumin alone. Asthma phenotypes, including airway-hyperresponsiveness (AHR),
Angiogenesis is critical and indispensable for tumor progression. Since VEGF is known to play a central role in angiogenesis, the disruption of VEGF-VEGF receptor system is a promising target for anti-cancer therapy. Previously, we reported that a hexapeptide (RRKRRR, RK6) blocked the growth and metastasis of tumor by inhibiting VEGF binding to its receptors. In addition, dRK6, the D-form derivative of RK6, retained its biological activity with improved serum stability. In the present study, we
Asthma is characterized by airway inflammation induced by immune dysfunction to inhaled antigens. Although respiratory viral infections are the most common cause of asthma exacerbation, immunologic mechanisms underlying virus-associated asthma exacerbation are controversial. Clinical evidence indicates that nitric oxide (NO) levels in exhaled air are increased in exacerbated asthma patients compared to stable patients. Here, we evaluated the immunologic mechanisms and the role of NO synthases (N
T-helper (Th)17 cell responses are important for the development of neutrophilic inflammatory disease. Recently, we found that acetyl salicylic acid (ASA) inhibited Th17 airway inflammation in an asthma mouse model induced by sensitization with lipopolysaccharide (LPS)-containing allergens. To investigate the mechanism(s) of the inhibitory effect of ASA on the development of Th17 airway inflammation, a neutrophilic asthma mouse model was generated by intranasal sensitization with LPS plus ovalbu
Theophylline is commonly used to treat severe asthma and chronic obstructive pulmonary disease (COPD)characterized by non-eosinophilic inflammation. Acetyl salicylic acid (ASA) is one of the most widely used medications worldwide, but up to 20% of patients with asthma experience aggravated respiratory symptoms after taking ASA. Here we evaluated the adverse effect of ASA on the therapeutic effect of theophylline in mice with non-eosinophilic asthma. A non-eosinophilic asthma mouse model was indu
Dive deeper into Yongsung Ko's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.